Vivani Medical(VANI)
$1.050.00 (0.00%)
VANI
Vivani Medical financials statements
$1.05
At close:0.00 (0.00%)
Want to see VANI full AI Analyst Report?
Vivani Medical (VANI) Ratios
826 Followers
Vivani Medical Ratios
VANI's free cash flow for Q3 2026 was $-6.39M. For the 2026 fiscal year, VANI's free cash flow was increased by $0.00 and operating cash flow was $-6.39M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.71 | 3.41 | 4.03 | 6.97 | 1.18 |
| Quick Ratio | 2.71 | 3.41 | 4.03 | 6.97 | 1.18 |
| Cash Ratio | 2.46 | 3.07 | 3.61 | 6.61 | 1.04 |
| Solvency Ratio | -1.11 | -0.96 | -1.01 | -1.98 | -4.16 |
| Operating Cash Flow Ratio | -3.68 | -3.47 | -4.14 | -2.75 | -5.25 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -5.76M | $ -3.51M | $ -1.97M | $ 40.71M | $ -519.00K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.48 | 0.46 | 0.45 | 0.02 | 0.33 |
| Debt-to-Equity Ratio | 1.20 | 1.10 | 1.00 | 0.02 | 0.74 |
| Debt-to-Capital Ratio | 0.55 | 0.52 | 0.50 | 0.02 | 0.42 |
| Long-Term Debt-to-Capital Ratio | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.50 | 2.36 | 2.21 | 1.15 | 2.21 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.30 | 0.35 | 0.41 | 0.02 | 0.05 |
| Net Debt to EBITDA | -0.10 | -0.04 | -0.00 | 2.30 | 0.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 96.56% | 95.17% | 95.13% | 65.39% | 95.87% |
| Return on Assets (ROA) | -67.55% | -56.51% | -56.01% | -27.16% | -234.24% |
| Return on Equity (ROE) | -169.16% | -133.37% | -123.56% | -31.35% | -518.17% |
| Return on Capital Employed (ROCE) | -84.04% | -69.37% | -67.29% | -47.94% | -395.69% |
| Return on Invested Capital (ROIC) | -79.68% | -66.83% | -65.04% | -46.93% | -311.50% |
| Return on Tangible Assets | -67.55% | -56.51% | -56.01% | -27.16% | -234.24% |
| Earnings Yield | -34.67% | -36.82% | -49.45% | -42.74% | -7.21% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.41 | 0.00 | 0.66 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -888.40 | 0.00 | -554.15 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 888.40 | 0.00 | 554.15 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.39 | -0.38 | -0.47 | -0.49 | -0.30 |
| Free Cash Flow Per Share | -0.41 | -0.39 | -0.48 | -0.50 | -0.32 |
| Dividend Paid and CapEx Coverage Ratio | -20.73 | -37.38 | -26.72 | -55.58 | -19.15 |
| Capital Expenditure Coverage Ratio | -20.73 | -37.38 | -26.72 | -55.58 | -19.15 |
| Operating Cash Flow Coverage Ratio | -1.29 | -1.08 | -1.15 | -19.67 | -6.04 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -33.22% | -33.46% | -47.40% | -58.86% | -6.50% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.86 | -2.70 | -2.02 | -2.34 | -13.88 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 4.88 | 3.62 | 2.50 | 0.73 | 71.91 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.01 | -2.99 | -2.11 | -1.70 | -15.38 |
| Price-to-Operating Cash Flow Ratio | -3.16 | -3.07 | -2.19 | -1.73 | -16.19 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.19 | -0.01 | 0.05 | 0.00 |
| Enterprise Value Multiple | -3.03 | -2.80 | -2.05 | 0.61 | -13.63 |
| Enterprise Value | 79.36M | 64.74M | 51.91M | -11.63M | 176.90M |
| EV to EBITDA | -3.03 | -2.80 | -2.05 | 0.61 | -13.63 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -3.11 | -3.03 | -2.11 | 0.61 | -15.35 |
| EV to Operating Cash Flow | -3.26 | -3.11 | -2.19 | 0.62 | -16.15 |
| Tangible Book Value Per Share | 0.25 | 0.32 | 0.41 | 1.16 | 0.07 |
| Shareholders’ Equity Per Share | 0.25 | 0.32 | 0.41 | 1.16 | 0.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.43 | -0.43 | -0.50 | -0.36 | -0.35 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 0.71 | 0.96 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.91 | 0.89 | 0.92 | 1.35 | 0.86 |
Currency in USD

